
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
Donanemab has previously been approved in a number of other countries, including the United States.

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
Donanemab has previously been approved in a number of other countries, including the United States.